DPIIT recognised startup Government of India
Startup India
Supravitz Lifesciences Private Limited - healthcare in Indrad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹16.3 Cr
▲ 58% YoY
Net profit · FY 2025
₹56.19 Lakh
Net margin 3.4%
EBITDA · FY 2025
₹2.29 Cr
EBITDA margin 14.1%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹11.71 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
14
Provident fund records
About Supravitz Lifesciences Private Limited
Data last updated:
Supravitz Lifesciences Private Limited is a private limited company based in Indrad, Gujarat, India, recognised as a startup by DPIIT. It operates in the preventive health supplements segment of the healthcare sector. It was incorporated on 25 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U15549GJ2017PTC098833. Its GSTIN is 24AAZCS1360D1ZA (Gujarat).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Dipak Kumar Tibrewal and Pradeep Kumar Sahal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 103 – 104 Kamla Amrut Ind. Park Taluka – Kadi, Indrad, Gujarat, India – 382715.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.3 Cr, a growth of 58% compared to the previous year. For the same year it recorded a net profit of ₹56.19 Lakh (net margin 3.4%) and EBITDA of ₹2.29 Cr (EBITDA margin 14.1%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 41% over five years.
The company has about 14 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹11.71 Cr on record.
Supravitz Lifesciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-14-0003665). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website supravitzlifesciences.com.
Company details
CIN U15549GJ2017PTC098833
Registration Number 098833
Incorporation Date 25 August 2017
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-GJ-14-0003665
Recognitions & Rankings of Supravitz Lifesciences
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-14-0003665
Contact details
Supravitz Lifesciences Private Limited's registered office is in Indrad, Gujarat. Its website is supravitzlifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 103 – 104 Kamla Amrut Ind. Park Taluka – Kadi, Indrad, Gujarat, India – 382715
- IndustryHealthcare, Preventive Health Supplements
To see the full contact details of Supravitz Lifesciences Private Limited, buy the company report.
Comprehensive company report
Supravitz Lifesciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Supravitz Lifesciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Supravitz Lifesciences Private Limited, buy the company report.
Financials of Supravitz Lifesciences Private Limited
FY 2024 filings availableSupravitz Lifesciences Private Limited reported revenue of ₹16.3 Cr (up 58% YoY) for FY 2025.
Revenue · FY 2025
₹16.3 Cr ▲ 58%
Net profit · FY 2025
₹56.19 Lakh margin 3.4%
EBITDA · FY 2025
₹2.29 Cr margin 14.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 58%
3 years · compounded
▲ 27%
5 years · compounded
▲ 41%
EBITDA CAGR growth
1 year
▲ 66%
3 years · compounded
▲ 42%
5 years · compounded
▲ 22%
Revenue has grown at a compounded annual rate (CAGR) of 41% over five years, including 58% growth in the latest year. EBITDA rose 66% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.29 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹56.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.1% | ||||
| Net Profit Margin | 3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Supravitz Lifesciences Private Limited, buy the company report.
Board of directors of Supravitz Lifesciences Private Limited
Supravitz Lifesciences has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dipak Kumar Tibrewal Also directs: Doleshwor Pharmaceuticals Private Limited | Director | 25 Aug 2017 | 9 Years 2 Months | Current |
| Pradeep Kumar Sahal Also directs: Nuramed Lifesciences LLP, Nuramed Pharmaceuticals Private Limited | Director | 25 Aug 2017 | 9 Years 2 Months | Current |
| Rajesh Kumar Agarwal | Director | 25 Aug 2017 | 9 Years 2 Months | Current |
Peer comparison
Supravitz Lifesciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Lifesciences), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunrise Lifesciences Private Limited | ₹17.01 Cr (FY 2024) | 149.0% | Mumbai, Maharashtra, India | |||
| CMR Lifesciences Private Limited | ₹16.76 Cr (FY 2025) | -9.0% | Ahmedabad, Gujarat, India | |||
| Bipi Lifesciences Private Limited | ₹16.5 Cr (FY 2025) | 13.0% | Ahmedabad, Gujarat, India | |||
| Supravitz Lifesciences Private Limitedthis company | ₹16.3 Cr (FY 2025) | ₹56.19 Lakh | 3.4% | 58.0% | 14 | Indrad, Gujarat, India |
| Atos Lifesciences Private Limited | ₹15.78 Cr (FY 2024) | 49.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Supravitz Lifesciences Private Limited, buy the company report.
Auditor
Supravitz Lifesciences Private Limited is audited by Sameer Ghanchi & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sameer Ghanchi & Associates | FY 2024 | 131796W |
Shareholding
The shareholding of Supravitz Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Supravitz Lifesciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹11.71 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jun 2020 | 100371872 | Others | ₹7.51 Cr | Open | |
| 14 Feb 2018 | 100166891 | Vijaya Bank | ₹2.1 Cr | Open | |
| 23 Jan 2018 | 100166505 | Vijaya Bank | ₹2.1 Cr | Open |
To see the full charge records of Supravitz Lifesciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Supravitz Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Supravitz Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Supravitz Lifesciences Private Limited has a workforce of 14 employees on its EPFO records as of Mar 27, 2025, across 1 active EPFO establishment.
Employee count
14
Active EPFO establishments
1
GST
Supravitz Lifesciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAZCS1360D1ZA | Gujarat | Active | 13 Nov 2017 |
To see the full GST registrations and return filing status of Supravitz Lifesciences Private Limited, buy the company report.
Recent activity
Supravitz Lifesciences Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Dipak Kumar Tibrewal was appointed as Director on 25 Aug 2017.
AGM
Supravitz Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others of Rs. 7.51 Cr registered on 09 Jun 2020 with Charge ID 100371872 was modified on 25 Sep 2024.
Filing
Supravitz Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 7.51 Cr with Charge ID 100371872 was registered on 09 Jun 2020.
Charges
A charge with Vijaya Bank amounted to Rs. 2.10 Cr with Charge ID 100166891 was registered on 14 Feb 2018.
Charges
A charge with Vijaya Bank amounted to Rs. 2.10 Cr with Charge ID 100166505 was registered on 23 Jan 2018.
Appointed
Dipak Kumar Tibrewal was appointed as Director.
Appointed
Pradeep Kumar Sahal was appointed as Director.
Appointed
Rajesh Kumar Agarwal was appointed as Director.
Incorporation
25 Aug 2017
Supravitz Lifesciences Private Limited was registered on 25 Aug 2017 with Roc Ahmedabad & aged 9 years 2 months as per MCA records.
Frequently asked questions
Supravitz Lifesciences is an active private limited company based in Indrad, Gujarat, India. The company works in preventive health supplements, within the healthcare industry. It was incorporated on 25 August 2017 (9+ years old) and is registered under CIN U15549GJ2017PTC098833.
Supravitz Lifesciences has 3 current directors:
- Dipak Kumar Tibrewal - Director
- Pradeep Kumar Sahal - Director
- Rajesh Kumar Agarwal - Director
The latest financial statements of Supravitz Lifesciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Supravitz Lifesciences is 24AAZCS1360D1ZA, registered in Gujarat.
The CIN (Corporate Identification Number) of Supravitz Lifesciences is U15549GJ2017PTC098833. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Supravitz Lifesciences was incorporated on 25 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Supravitz Lifesciences by revenue are Sunrise Lifesciences Private Limited, CMR Lifesciences Private Limited, Bipi Lifesciences Private Limited, Atos Lifesciences Private Limited, all in the Pharma industry (Lifesciences), with the same principal business activity (wholesale trading).
Dipak Kumar Tibrewal was appointed as Director on 25 Aug 2017. Pradeep Kumar Sahal was appointed as Director on 25 Aug 2017. Rajesh Kumar Agarwal was appointed as Director on 25 Aug 2017.
Yes, Supravitz Lifesciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Supravitz Lifesciences is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-14-0003665).
Supravitz Lifesciences can be reached through the website supravitzlifesciences.com. Its registered office is in Indrad, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages